Bill Power

Chief Corporate Development & Strategy Officer at Nirvana Health

Bill Power has over 25 years of experience in various leadership roles. Bill currently serves as the Chief Corporate Development & Strategy Officer at nirvanaHealth | RxAdvance since January 2022. In this position, they are responsible for developing and executing the company's capital raising activities and providing strategic guidance to the CEO and board of directors.

Prior to their current role, Bill was the Chief Relationship Officer at Choate, Hall & Stewart LLP from March 2021 to January 2022. In this role, they focused on strengthening and expanding the firm's relationships with clients and prospects across various areas of practice.

Before joining Choate, Bill spent 24 years at Citi, where they served as a Managing Director and led the Citi Private Company Access initiative. This initiative aimed to connect private company executives with institutional investors and foster new business development opportunities.

Additionally, Bill has served as a Board Member at JDRF Greater New England from June 2014 to May 2020, demonstrating their commitment to philanthropic endeavors.

Throughout their career, Bill has demonstrated expertise in business development, relationship management, and strategic planning, making him a valuable asset in driving organizational growth and value creation.

Bill Power attended the Boston College Carroll School of Management from 1989 to 1993. Bill obtained a degree in Business, Management, and Marketing from the Carroll School of Management during that time. In addition to their formal education, Bill also obtained several certifications. In December 2021, they received the Amazon Web Services Cloud Practitioner certification from Amazon Web Services (AWS). In February 2022, they completed the AWS Technical Essentials certification. Furthermore, in March 2022, Bill obtained the MIT Sloane Artificial Intelligence in Healthcare certification from the MIT Sloan School of Management.

Links

Timeline

  • Chief Corporate Development & Strategy Officer

    January, 2022 - present

View in org chart